Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

March 01, 2016; Volume 356,Issue 3

Minireview

  • You have access
    The Utility of Impulsive Bias and Altered Decision Making as Predictors of Drug Efficacy and Target Selection: Rethinking Behavioral Screening for Antidepressant Drugs
    Gerard J. Marek, Mark Day and Thomas J. Hudzik
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 534-548; DOI: https://doi.org/10.1124/jpet.115.229922

Behavioral Pharmacology

  • You have access
    Spinal Functions of B-Type Natriuretic Peptide, Gastrin-Releasing Peptide, and Their Cognate Receptors for Regulating Itch in Mice
    Norikazu Kiguchi, Devki D. Sukhtankar, Huiping Ding, Ken-ichi Tanaka, Shiroh Kishioka, Christopher M. Peters and Mei-Chuan Ko
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 596-603; DOI: https://doi.org/10.1124/jpet.115.229997
  • You have access
    Stereoselective Effects of Abused “Bath Salt” Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation
    Brenda M. Gannon, Adrian Williamson, Masaki Suzuki, Kenner C. Rice and William E. Fantegrossi
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 615-623; DOI: https://doi.org/10.1124/jpet.115.229500
  • You have access
    An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund’s Adjuvant Rat Model of Arthritis
    F. T. Bonezzi, O. Sasso, S. Pontis, N. Realini, E. Romeo, S. Ponzano, A. Nuzzi, A. Fiasella, F. Bertozzi and D. Piomelli
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 656-663; DOI: https://doi.org/10.1124/jpet.115.230516

Cardiovascular

  • You have access
    Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery
    Hicham Labazi, Stephen L. Tilley, Catherine Ledent and S. Jamal Mustafa
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 673-680; DOI: https://doi.org/10.1124/jpet.115.230144
  • You have access
    Cocaine Hydrolase Gene Transfer Demonstrates Cardiac Safety and Efficacy against Cocaine-Induced QT Prolongation in Mice
    Vishakantha Murthy, Santiago Reyes, Liyi Geng, Yang Gao and Stephen Brimijoin
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 720-725; DOI: https://doi.org/10.1124/jpet.115.228825

Cellular and Molecular

  • You have access
    20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding
    Victor Garcia, Brian Shkolnik, Laura Milhau, John R. Falck and Michal Laniado Schwartzman
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 525-533; DOI: https://doi.org/10.1124/jpet.115.229377
  • You have access
    Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors
    Céline Legros, Chantal Brasseur, Philippe Delagrange, Pierre Ducrot, Olivier Nosjean and Jean A. Boutin
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 681-692; DOI: https://doi.org/10.1124/jpet.115.229989

Drug Discovery and Translational Medicine

  • You have access
    Modeling Respiratory Depression Induced by Remifentanil and Propofol during Sedation and Analgesia Using a Continuous Noninvasive Measurement of pCO2
    Jacqueline A. Hannam, Xavier Borrat, Iñaki F. Trocóniz, José F. Valencia, Erik W. Jensen, Angela Pedroso, Jenifer Muñoz, Sergi Castellví-Bel, Antoni Castells and Pedro L. Gambús
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 563-573; DOI: https://doi.org/10.1124/jpet.115.226977
  • You have access
    Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells
    Irene Tsilioni, Irwin J. Russell, Julia M. Stewart, Rae M. Gleason and Theoharis C. Theoharides
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 664-672; DOI: https://doi.org/10.1124/jpet.115.230060
  • You have access
    A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 Rat
    Carine M. Boustany-Kari, Paul C. Harrison, Hongxing Chen, Kathleen A. Lincoln, Hu Sheng Qian, Holly Clifford, Hong Wang, Xiaomei Zhang, Kristina Gueneva-Boucheva, Todd Bosanac, Diane Wong, Ryan M. Fryer, Jeremy G. Richman, Chris Sarko and Steven S. Pullen
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 712-719; DOI: https://doi.org/10.1124/jpet.115.230706

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    ASB14780, an Orally Active Inhibitor of Group IVA Phospholipase A2, Is a Pharmacotherapeutic Candidate for Nonalcoholic Fatty Liver Disease
    Shiho Kanai, Keiichi Ishihara, Eri Kawashita, Toshiyuki Tomoo, Kazuhiro Nagahira, Yasuhiro Hayashi and Satoshi Akiba
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 604-614; DOI: https://doi.org/10.1124/jpet.115.229906

Inflammation, Immunopharmacology, and Asthma

  • You have access
    The Role of Anti-Drug Antibodies in the Pharmacokinetics, Disposition, Target Engagement, and Efficacy of a GITR Agonist Monoclonal Antibody in Mice
    Nicholas D. Brunn, Smita Mauze, Danling Gu, Derek Wiswell, Roanna Ueda, Douglas Hodges, Amy M. Beebe, Shuli Zhang and Enrique Escandón
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 574-586; DOI: https://doi.org/10.1124/jpet.115.229864
  • You have access
    Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia
    Srinivasan Chandrasekhar, Anita K. Harvey, Xiao-Peng Yu, Mark G. Chambers, Jennifer L. Oskins, Chaohua Lin, Thomas W. Seng, Stefan J. Thibodeaux, Bryan H. Norman, Norman E. Hughes, Matthew A. Schiffler and Matthew J. Fisher
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 635-644; DOI: https://doi.org/10.1124/jpet.115.228932

Neuropharmacology

  • Open Access
    Noncompetitive Inhibition of 5-HT3 Receptors by Citral, Linalool, and Eucalyptol Revealed by Nonlinear Mixed-Effects Modeling
    Gavin E. Jarvis, Roseli Barbosa and Andrew J. Thompson
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 549-562; DOI: https://doi.org/10.1124/jpet.115.230011
  • You have access
    The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models
    Eri Shiraishi, Kazunori Suzuki, Akina Harada, Noriko Suzuki and Haruhide Kimura
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 587-595; DOI: https://doi.org/10.1124/jpet.115.230482
  • You have access
    2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations
    Weimin C. Hong, Theresa A. Kopajtic, Lifen Xu, Stacey A. Lomenzo, Bernandie Jean, Jeffry D. Madura, Christopher K. Surratt, Mark L. Trudell and Jonathan L. Katz
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 624-634; DOI: https://doi.org/10.1124/jpet.115.230722
  • You have access
    A Stress-Related Peptide Bombesin Centrally Induces Frequent Urination through Brain Bombesin Receptor Types 1 and 2 in the Rat
    Takahiro Shimizu, Shogo Shimizu, Youichirou Higashi, Kumiko Nakamura, Naoki Yoshimura and Motoaki Saito
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 693-701; DOI: https://doi.org/10.1124/jpet.115.230334
  • GluN2D <em>N</em>-Methyl-<span class="sc">d</span>-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia
    You have access
    GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia
    Kiran Sapkota, Zhihao Mao, Paul Synowicki, Dillon Lieber, Meng Liu, Tsuneya Ikezu, Vivek Gautam and Daniel T. Monaghan
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 702-711; DOI: https://doi.org/10.1124/jpet.115.230391

Toxicology

  • You have access
    Diisopropylfluorophosphate Impairs the Transport of Membrane-Bound Organelles in Rat Cortical Axons
    Jie Gao, Sean X. Naughton, Heike Wulff, Vikrant Singh, Wayne D. Beck, Jordi Magrane, Bobby Thomas, Navneet Ammal Kaidery, Caterina M. Hernandez and Alvin V. Terry
    Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 645-655; DOI: https://doi.org/10.1124/jpet.115.230839
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 356 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 356, Issue 3
1 Mar 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Behavioral Pharmacology
  • Cardiovascular
  • Cellular and Molecular
  • Drug Discovery and Translational Medicine
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Neuropharmacology
  • Toxicology
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Nose-to-Brain Delivery
  • Antipsychotic-VMAT2 Inhibitor Synergy: Schizophrenia Models
  • SEP-363856, a Novel, Non-D2 Psychotropic Agent
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics